Viramune® (nevirapine) receives CHMP recommendation for approval
27 July 2011 | By Boehringer Ingelheim
The CHMP issued a Positive Opinion recommending the approval of Viramune® (nevirapine)...
List view / Grid view
27 July 2011 | By Boehringer Ingelheim
The CHMP issued a Positive Opinion recommending the approval of Viramune® (nevirapine)...
22 July 2011 | By Takeda Pharmaceutical Company Limited
The EMA has recommended changes to the label of pioglitazone-containing medicines...
20 May 2011 | By GlaxoSmithKline
The CHMP has issued a positive opinion, recommending marketing authorisation for Benlysta® (belimumab)...
20 May 2011 | By Amgen
Amgen announced that the CHMP of the EMA has recommended a positive opinion for the marketing authorization of XGEVA™ (denosumab)...
20 May 2011 | By Merck
Merck announced that the CHMP of the EMA has adopted a positive opinion under accelerated assessment recommending approval of the investigational medicine VICTRELIS™...
20 May 2011 | By Biogen Idec
Biogen Idec announced that FAMPYRA(R) (prolonged-release fampridine tablets) has been granted a positive opinion for conditional approval from the EMA's CHMP...